Home
  >  
Section 29
  >  
Chapter 28,026

Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn

Beck, R.; Anderson, K.D.; Pearson, G.D.; Cronin, J.; Miller, M.K.; Short, B.L.

Journal of Pediatric Surgery 21(4): 297-302

1986

ISSN/ISBN: 0022-3468
PMID: 3084751
DOI: 10.1016/s0022-3468(86)80188-9
Accession: 028025065
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Extracorporeal membrane oxygenation (ECMO) has been available since 1975 as a therapy of last resort to provide adequate oxygenation for term infants with acute lung disorders that do not respond to maximal medical therapy. Virtually all term infants with serious lung disease have persistent pulmonary hypertension of the newborn (PPHN) characterized by significant right-to-left shunting of blood and severe diffusion defects manifested as increased alveolar-arterial oxygen gradients (AaDO2). Criteria for initiation of ECMO therapy have been developed in several institutions but at the present time there are no universal criteria applicable to all infants with PPHN. We have attempted to establish entry criteria that may be used for different populations of infants with PPHN. Based on a retrospective review of 30 infants with PPHN in our institution, we have defined standards of maximal medical therapy. An alveolar-arterial oxygen difference (AaDO2) of greater than or equal to 610 for 8 hours has been shown to be associated with 79% mortality in this population. This AaDO2/time interval is established as a major criterion for institution of extracorporeal membrane oxygenation.

PDF emailed within 0-6 h: $19.90




Related References

Visser, V.E.; Cook, J.; Hamilton, J.P.; Hickey, D.E.; Morton, D.; Rathbun, M.A. 1991: Extracorporeal membrane oxygenation for newborn infants with persistent pulmonary hypertension North Carolina Medical Journal 52(9): 416-420
Curtis, S.E.; Thompson, A.E.; Motoyama, E.K. 1989: Pulmonary function in infants on extracorporeal membrane oxygenation ecmo for persistent pulmonary hypertension of the newborn pphn American Review of Respiratory Disease 139(4 Part 2): A437
Christou, H.; Van Marter, L.J.; Wessel, D.L.; Allred, E.N.; Kane, J.W.; Thompson, J.E.; Stark, A.R.; Kourembanas, S. 2000: Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn Critical Care Medicine 28(11): 3722-3727
Marro, P.; Baumgart, S.; Phillips, S.; Corcoran, L.; Zirin, S.; Schnaufer, L.; Delivoria Papadopoulos, M.; Clancy, R. 1993: Purine metabolism and xanthine oxidase inhibition during extracorporeal membrane oxygenation in newborn infants with persistent pulmonary hypertension Pediatric Research 33(4 Part 2): 225A
Perez-Benavides, F.; Boynton, B.R.; Desai, N.S.; Goldthorn, J.F. 1993: Persistent pulmonary hypertension of the newborn infant. Comparison of conventional versus extracorporeal membrane oxygenation in neonates fulfilling Bartlett's criteria Journal of perinatology: official journal of the California Perinatal Association 13(3): 181-185
Chen, Y.-L.; Yang, X.-F.; Chen, J.; Shi, S.-W.; Zhu, Q.-W.; Liao, X.-Z.; Zhang, M.-G. 2022: Application of extracorporeal membrane oxygenation in the treatment of persistent pulmonary hypertension of the newborn Zhongguo Dang Dai Er Ke Za Zhi 24(7): 786-791
Hansen, T.W.; Sponheim, S.; Pedersen, T.; Svennevig, J. 1995: Persistent pulmonary hypertension in a newborn infant treated with extracorporeal membrane oxygenation Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(5): 591-594
Dworetz, A.R.; Moya, F.R.; Sabo, B.; Gladstone, I.; Gross, I. 1989: Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation Pediatrics 84(1): 1-6
Kimball, T.R.; Daniels, S.R.; Weiss, R.G.; Meyer, R.A.; Hannon, D.W.; Ryckman, F.C.; Tian, J.; Shukla, R.; Schwartz, D.C. 1991: Changes in cardiac function during extracorporeal membrane oxygenation for persistent pulmonary hypertension in the newborn infant Journal of Pediatrics 118(3): 431-436
Takata, M.; Miyasaka, K.; Sakai, H.; Fujiwara, H.; Ito, Y.; Kawano, T. 1995: Inhaled nitric oxide and extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn Acta Paediatrica Japonica: Overseas Edition 37(2): 171-173
Song, S.; Park, K.H.; Lee, H.; Lee, N.H. 2022: Veno-arterial extracorporeal membrane oxygenation for treatment of persistent pulmonary hypertension of the newborn Asian Journal of Surgery 2022
Burton, P.R.; Gurrin, L.C.; Hussey, M.H. 1997: Interpreting the clinical trials of extracorporeal membrane oxygenation in the treatment of persistent pulmonary hypertension of the newborn Seminars in Neonatology 2(1): 69-79
Varnholt, V.; Lasch, P.; Suske, G.; Kachel, W.; Brands, W. 1992: High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn European Journal of Pediatrics 151(10): 769-774
Hoffman, G.M.; Ross, G.A.; Day, S.E.; Rice, T.B.; Nelin, L.D. 1997: Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn Critical Care Medicine 25(2): 352-359
Müller, W.; Kachel, W.; Lasch, P.; Varnholt, V.; König, S. 1996: Inhaled nitric oxide during extracorporeal membrane oxygenation for the treatment of severe persistent pulmonary hypertension of the newborn Artificial Organs 20(1): 60-63
Sola, A.; Rogido, M.R.; Farina, D.; Tornow, S.L. 1989: Indicators of severity in persistent pulmonary hypertension pph are published criteria for extracorporeal membrane oxygenation ecmo valid Pediatric Research 25(4 Part 2): 232A
Dworetz, A.R.; Gladstone, I.M.; Moya, F.R.; Sabo, B.; Gross, I. 1989: Survival of infants with severe persistent pulmonary hypertension pph without extracorporeal membrane oxygenation ecmo an update Pediatric Research 25(4 Part 2): 214A
Muller, W.; Kachel, W.; Lasch, P.; Varnholt, V.; Konig, S.A. 1996: Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn Intensive Care Medicine 22(1): 71-76
Pfenninger, J.; Bachmann, D.C.; Wagner, B.P. 1997: Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn Intensive Care Medicine 23(2): 233
Dollberg, S.; Warner, B.W.; Myatt, L. 1995: Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation Pediatric Research 37(1): 31-34